Watch patient story videos discussing their Tardive Dyskinesia (TD) and experiences with AUSTEDO XR® extended release tablets. See safety info and boxed warning.

Sep 20, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …

Sep 20, 2025 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) …

Oct 22, 2025 · She added, “These data articulate patient experience and further validate clinical research showing how AUSTEDO or AUSTEDO XR can help people living with tardive …

Dec 2, 2025 · “These data articulate patient experience and further validate clinical research showing how AUSTEDO or AUSTEDO XR can help people living with tardive dyskinesia …

Sep 21, 2025 · Patient Satisfaction with AUSTEDO XR: A survey of 209 patients with tardive dyskinesia (TD) revealed that over 94% experienced movement improvement after treatment …

Sep 21, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …

Nov 1, 2024 · Teva also announced interim data from a patient-reported survey describing early, real-world experience with AUSTEDO XR. These findings are being presented at the Psych …

Nov 2, 2024 · Teva also presented findings on real-world patient experience with AUSTEDO XR from a non-interventional, prospective, cross-sectional survey, which included adults with TD …

Nov 7, 2024 · The majority of people with TD or chorea associated with Huntington disease (HD) who were treated with Austedo XR (deutetrabenazine; Teva Neuroscience, Kansas City, MO) …